{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:35:23Z","timestamp":1794958523575,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016112","name":"Universit\u00e0 di Foggia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory processes are thought to contribute to the development and progression of prostate cancer (PCa). This study aimed to evaluate whether a novel Prostatic Inflammation Score (PIS), integrating Irani Grade (G) and Aggressiveness (A), could predict the risk of biochemical recurrence (BCR) following radical prostatectomy (RP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients undergoing biopsy and RP between 2013 and 2023 were included. PIS was assessed on hematoxylin and eosin-stained biopsy cores: PIS 1 (G 0\u20131\/A 0\u20131), PIS 2 (G 2\u20133\/A 0\u20131), and PIS 3 (G 0\u20133\/A 2\u20133). BCR, considered as two consecutive PSA readings of \u2265\u20090.2 ng\/mL, was evaluated through multivariable Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 679 patients (median follow-up: 36 months), 127 (18.7%) experienced BCR. Over a median follow-up of 36 months, 127 (18.7%) patients experienced BCR. BCR incidence at six years was highest in PIS 1 (30%) vs. PIS 2 (10%) and PIS 3 (9%) (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002). Compared to PIS 1, hazard ratios (HR) for BCR were 0.44 (95% CI: 0.27\u20130.74) for PIS 2 and 0.37 (95% CI: 0.15\u20130.91) for PIS 3. IRANI G scores inversely correlated with BCR risk (HR = 0.44, 95% CI: 0.27\u20130.74), while IRANI A scores (2\u20133) showed a nonsignificant trend (HR = 0.41, 95% CI: 0.17\u20131.02,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.054). Gleason grade and pT stage were significantly associated with BCR, while margin status and pN stage were not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PIS 1 was found to be associated with BCR after RP. Should these findings be externally validated, PIS could represent a readily available inexpensive tool to predict BCR after RP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-05977-8","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:36:26Z","timestamp":1759998986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy"],"prefix":"10.1007","volume":"43","author":[{"given":"Francesco","family":"Guzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo Giovanni","family":"Falagario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ninivaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Finati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"d\u2019Altilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggiero Antonio","family":"Fiorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Bettocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Conteduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"11","key":"5977_CR1","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603\u20131616","journal-title":"Free Radic Biol Med"},{"issue":"7203","key":"5977_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"6917","key":"5977_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867","journal-title":"Nature"},{"issue":"5","key":"5977_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117(5):1137\u20131146","journal-title":"J Clin Invest"},{"issue":"10","key":"5977_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrurol.2016.168","volume":"13","author":"C De Nunzio","year":"2016","unstructured":"De Nunzio C, Presicce F, Tubaro A (2016) Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 13(10):613\u2013626","journal-title":"Nat Rev Urol"},{"issue":"2","key":"5977_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MOU.0000000000000369","volume":"27","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia G, Zaffuto E, Fossati N, Cucchiara V, Mirone V, Montorsi F et al (2017) The role of prostatic inflammation in the development and progression of benign and malignant diseases. Curr Opin Urol 27(2):99\u2013106","journal-title":"Curr Opin Urol"},{"issue":"2","key":"5977_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163","journal-title":"Eur Urol"},{"issue":"5","key":"5977_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453\u2013457","journal-title":"Nat Methods"},{"issue":"4","key":"5977_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.gene.6364173","volume":"6","author":"AR Abbas","year":"2005","unstructured":"Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F et al (2005) Immune response in Silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 6(4):319\u2013331","journal-title":"Genes Immun"},{"issue":"4","key":"5977_CR10","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, Bon D, Dor\u00e9 B, Aubert J (1997) Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157(4):1301\u20131303","journal-title":"J Urol"},{"issue":"4","key":"5977_CR11","first-page":"178","volume":"66","author":"U Falagario","year":"2018","unstructured":"Falagario U, Selvaggio O, Carrieri G, Barret E, Sanguedolce F, Cormio L (2018) Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer. J Gerontol Geriatr 66(4):178\u2013182","journal-title":"J Gerontol Geriatr"},{"key":"5977_CR12","doi-asserted-by":"crossref","unstructured":"Gravas S, De Nunzio C, Campos Pinheiro L,Ponce de Le\u00f3n J, Skriapas K, Milad Z, Lombardo R, Medeiros M, Makrides P, Samarinas M, Gacci M. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis. 2025 Jun;28(2):405-410.doi: 10.1038\/s41391-024-00857-5. Epub 2024 Jul 6. PMID: 38971935; PMCID: PMC12106073.","DOI":"10.1038\/s41391-024-00857-5"},{"issue":"11","key":"5977_CR13","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00345-020-03106-1","volume":"38","author":"C De Nunzio","year":"2020","unstructured":"De Nunzio C, Salonia A, Gacci M, Ficarra V (2020) Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia. World J Urol 38(11):2771\u20132779","journal-title":"World J Urol"},{"issue":"10","key":"5977_CR14","doi-asserted-by":"publisher","first-page":"793e19","DOI":"10.1016\/j.urolonc.2020.02.025","volume":"38","author":"F Sanguedolce","year":"2020","unstructured":"Sanguedolce F, Falagario UG, Castellan P, Di Nauta M, Silecchia G, Bruno SM et al (2020) Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer. Urol Oncol 38(10):793e19\u2013e25","journal-title":"Urol Oncol"},{"key":"5977_CR15","doi-asserted-by":"crossref","unstructured":"Falagario UG, Sanguedolce F, Cormio A, Ninivaggi A, Finati M, Guzzi F, Busetto GM, Bettocchi C, Castellani D, Carrieri G, Cormio L. The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy. Diagnostics (Basel). 2025 Jan 13;15(2):166. doi: 10.3390\/diagnostics15020166. PMID: 39857050; PMCID: PMC11763971.","DOI":"10.3390\/diagnostics15020166"},{"issue":"1","key":"5977_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.urolonc.2010.09.004","volume":"31","author":"L Cormio","year":"2013","unstructured":"Cormio L, Lorusso F, Selvaggio O, Perrone A, Sanguedolce F, Pagliarulo V et al (2013) Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel. Urol Oncol 31(1):68\u201373","journal-title":"Urol Oncol"},{"issue":"12","key":"5977_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1464-410X.2011.10622.x","volume":"109","author":"L Cormio","year":"2012","unstructured":"Cormio L, Pagliarulo V, Lorusso F, Selvaggio O, Perrone A, Sanguedolce F et al (2012) Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. BJU Int 109(12):1776\u20131780","journal-title":"BJU Int"},{"issue":"2","key":"5977_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00345-012-0989-8","volume":"32","author":"L Cormio","year":"2014","unstructured":"Cormio L, Scattoni V, Lorusso F, Perrone A, Di Fino G, Selvaggio O et al (2014) Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? World J Urol 32(2):341\u2013346","journal-title":"World J Urol"},{"issue":"9","key":"5977_CR19","doi-asserted-by":"publisher","first-page":"e2332900","DOI":"10.1001\/jamanetworkopen.2023.32900","volume":"6","author":"UG Falagario","year":"2023","unstructured":"Falagario UG, Abbadi A, Remmers S, Bj\u00f6rnebo L, Bogdanovic D, Martini A et al (2023) Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy. JAMA Netw Open 6(9):e2332900","journal-title":"JAMA Netw Open"},{"issue":"23","key":"5977_CR20","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1158\/1078-0432.CCR-08-1716","volume":"14","author":"DL Blum","year":"2008","unstructured":"Blum DL, Koyama T, M\u2019Koma AE, Iturregui JM, Martinez-Ferrer M, Uwamariya C et al (2008) Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin Cancer Res 14(23):7790\u20137797","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5977_CR21","first-page":"831","volume":"16","author":"T Akashi","year":"2006","unstructured":"Akashi T, Koizumi K, Nagakawa O, Fuse H, Saiki I (2006) Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145. Oncol Rep 16(4):831\u2013836","journal-title":"Oncol Rep"},{"issue":"4","key":"5977_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1189\/jlb.69.4.531","volume":"69","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Nakazato H, Matsui H, Hasumi M, Shibata Y, Ito K et al (2001) NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: Immunogene therapy using a highly secretable form of interleukin-15 gene transfer. J Leukoc Biol 69(4):531\u2013537","journal-title":"J Leukoc Biol"},{"issue":"4","key":"5977_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1172\/JCI200422206","volume":"114","author":"JD Wu","year":"2004","unstructured":"Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR (2004) Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 114(4):560\u2013568","journal-title":"J Clin Invest"},{"issue":"3","key":"5977_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jnci\/djy141","volume":"111","author":"SG Zhao","year":"2019","unstructured":"Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y et al (2019) The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target. J Natl Cancer Inst 111(3):301\u2013310","journal-title":"J Natl Cancer Inst"},{"key":"5977_CR25","doi-asserted-by":"publisher","unstructured":"Madersbacher S, Sampson N, Culig Z (2019) Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology. ;65(5):458\u2013464. https:\/\/doi.org\/10.1159\/000496289. Epub 2019 Apr 3. PMID: 30943489","DOI":"10.1159\/000496289"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05977-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:04:16Z","timestamp":1767999856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05977-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5977"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05977-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Retrospectively enrolled patients provided informed consent to be included in our Institutional Database. The Institutional Review Board of University of Foggia waiver for informed consent was obtained prior to conducting this study in accordance with institutional regulations when dealing with de-identified previously collected data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Our research was carried out in accordance with the Declaration of Helsinki of the World Medical Association and has been approved by the Institutional Review Board of University of Foggia (protocol code 152\/CE\/2014).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"601"}}